Gossamer Bio GOSS
NASDAQ GOSS
$0.16 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) EBITDA Margin (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly EBITDA Margin of 264.62% for Q1 2026, up 10761.0% year-over-year from N/an in Q1 2025, and up 20.69% quarter-over-quarter from 333.64% in Q4 2025.

Gossamer Bio (GOSS) EBITDA Margin (2024 - 2026) Analysis & Trends

Gossamer Bio's EBITDA Margin history runs 3 years deep, the most recent figure standing at 264.62% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 10761.0% year-over-year to 264.62%; the TTM figure through Mar 2026 stood at 321.92% (down 26747.0% YoY), while the FY2025 annual figure was 352.23%, down 28616.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 264.62%, up from 333.64% in the prior quarter.
  • The five-year high for EBITDA Margin was 247.08% in Q4 2024, with the low at 372.23% in Q1 2025.
  • The 3-year median for EBITDA Margin is 335.52% (2025), against an average of 216.71%.
  • The sharpest annual moves came in 2025 and 2026: EBITDA Margin tumbled 58072 bps in 2025, then soared 10761 bps in 2026.
  • Gossamer Bio's EBITDA Margin stood at 247.08% in 2024, then sank by 235 bps to 333.64% in 2025, then advanced by 21 bps to 264.62% in 2026.
  • Business Quant data shows GOSS's EBITDA Margin at 264.62% in Q1 2026, 333.64% in Q4 2025, and 369.44% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 30.15%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 32.54%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -562.07%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 17.93%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.36%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 19.75%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -35.57%
10 Gossamer Bio 50.34 Mn -6.69 Mn - -282.25%

Historic Data

Download Data
DateValue
Jun 30, 2026 -282.25%
Mar 31, 2026 -264.62%
Dec 31, 2025 -333.64%
Sep 30, 2025 -369.44%
Jun 30, 2025 -337.41%
Mar 31, 2025 -372.23%
Dec 31, 2024 247.08%
Sep 30, 2024 -357.80%
Jun 30, 2024 54.35%